Product Formulation Statement definition

Product Formulation Statement means a manufacturer’s product formulation statement (PFS) is a signed certified document that provides a way for a manufacturer to demonstrate how a product may contribute to the meal pattern requirements of Child Nutrition (CN) programs. A PFS is typically provided for processed products that do not have a CN Label. Program operators may request a signed manufacturer’s PFS when purchasing a processed product without a CN Label. USDA does not approve a manufacturer’s PFS. Program operators are ultimately responsible for ensuring menu items meet meal pattern requirements.
Product Formulation Statement means a signed certified document that provides a way for a manufacturer to demonstrate how a product may contribute to the meal pattern requirements of Child Nutrition (CN) programs. A PFS is typically provided for processed products that do not have a CN Label. Program operators shall request a signed manufacturer’s PFS when purchasing a processed product without a CN Label. USDA does not approve a manufacturer’s PFS. Program operators are ultimately responsible for ensuring menu items meet meal pattern requirements.
Product Formulation Statement means a signed certified document that provides a way for a manufacturer to demonstrate how a product may contribute to the meal pattern requirements of Child Nutrition (CN) programs. A PFS is typically provided for processed products that do not have a CN Label. Program operators may request a signed manufacturer’s PFS when purchasing a processed product without a CN Label. USDA does not approve a manufacturer’s PFS. Program operators are ultimately responsible for ensuring menu items meet meal pattern requirements.“Request for Proposal,” or RFP, means the document used in soliciting bids through the formal advertising method of procurement. In the case of this program, the RFP becomes the contract upon acceptance by the SFA.

Examples of Product Formulation Statement in a sentence

  • Any substituted proposal items must include nutrient content documentation (Product Formulation Statement) that also contains specific information that includes saturated fat, sodium, and trans fat.

  • Will you provide in pdf format the following: Documentation of nutrition information to include Nutrition Facts Label, an ingredient statement and/or a CN label or Product Formulation Statement on manufacturer’s letterhead in pdf format, using your distribution item code as the file name for each item (e.g., if 1234567 is your distributor item code for ketchup, the nutrition information file name for ketchup would be 1234567.pdf).

  • Nutritional Analysis Data Sheets, including food allergen information, and CN labels (if applicable) MUST be included in each of the returned bid packets or complete the Product Formulation Statement for Documenting Grains in Child Nutrition Programs, the Product Formulation Statement for Documenting Vegetables and Fruits in School Meal Programs, and/or Product Formulation Statement for Documenting Meats/Meat Alternates (M/MA) form.

  • Product shall: be commercial brand products; have a shelf life of at least 50 days from date of manufacturer Combination main dish food items require a Child Nutrition (CN) Label, Product Formulation Statement (PFS), or standardized recipe.

  • Bidders must complete the Product Formulation Statement for Documenting Meat/Meat Alternate, Grains, and/or Vegetables and Fruit.

  • Nutrition Labels, Ingredient Labels and a signed Product Analysis/ Product Formulation Statement must be attached for all products submitted on this Proposal.

  • Samples are to be sent at NO CHARGE.All samples must include Nutrition Labels, Ingredient Labels and a signed Product Analysis/ Product Formulation Statement.

  • If a CN label is not required, obtain a Product Formulation Statement to determine the number of pieces per serving and document that portions meet requirements.

  • The whole grain-rich criteria provided in FNS guidance may be updated to reflect additional information provided voluntarily by industry on the food label, Product Formulation Statement (PFS), or a whole grains definition by the Food and Drug Administration.

  • Any substituted proposal items must include nutrient content documentation (Product Formulation Statement) that also contains specific information that includes saturated fat, sodium, and trans-fat.


More Definitions of Product Formulation Statement

Product Formulation Statement means a signed certified document that provides a way for a manufacturer to demonstrate how a product may contribute to the meal pattern requirements of Child Nutrition (CN) programs. A PFS is typically provided for processed products that do not have a CN Label. Program operators shall request a signed manufacturer’s PFS when purchasing a processed product without a CN Label.

Related to Product Formulation Statement

  • Development Plan has the meaning set forth in Section 3.2.

  • Product Schedule means a product schedule documenting the specific terms and conditions applying to a Product as may be amended, updated or replaced from time to time (and includes any Electronic Platform Schedules);

  • Destination state means the state, territory, or foreign country to which motor fuel is directed for

  • Termination statement means an amendment of a financing statement which:

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • NDA means a New Drug Application, as defined in the regulations promulgated by the United States Food and Drug Administration, or any foreign equivalent thereof.

  • Information Statement means the information statement to be made available to the holders of Parent Shares in connection with the Distribution, as such information statement may be amended or supplemented from time to time prior to the Distribution.

  • IND means an investigational new drug application filed with the FDA with respect to a Product, or an equivalent application filed with a Regulatory Authority in a country other than the United States to commence a clinical trial of pharmaceutical product.